Urology News and Research

Latest Urology News and Research

Prostate cancer patients more likely to receive medical care matched to level of risk

After decades of overtreatment for low-risk prostate cancer and inadequate management of its more aggressive forms, patients are now more likely to receive medical care matched to level of risk, according to a study by researchers at UC San Francisco.

25 Jul 2015

York scientists identify how some micro-RNAs can make prostate cancers resistant to radiotherapy

Scientists at the University of York believe they have identified how some tiny regulatory molecules in cells can make prostate cancers resistant to radiotherapy.

24 Jul 2015

UCLA Health's hospitals named among nation's best in U.S. News and World Report

UCLA Health's hospitals in Westwood and Santa Monica have been named to U.S. News and World Report's 2015-2016 Best Hospitals Honor Roll. UCLA, which previously ranked No. 5 in the country, tied for No. 3 this year.

22 Jul 2015

UC San Diego Health ranked again among nation's best hospitals by U.S. News & World Report

Once again, UC San Diego Health and its hospitals are ranked #1 in San Diego, and recognized among the best in the nation, by U.S. News & World Report for 2015-16. The annual U.S. News "Best Hospitals" rankings distinguish hospitals that excel in treating the most challenging health conditions.

21 Jul 2015

MD Anderson ranked No. 1 hospital in nation for cancer care

The University of Texas MD Anderson Cancer Center has been ranked the No. 1 hospital for cancer care in the nation by U.S. News & World Report's "Best Hospitals" survey.

21 Jul 2015

Allergan announces U.S. availability of SAPHRIS 2.5 mg tablets for children with bipolar I disorder

Allergan plc today announced that SAPHRIS (asenapine) 2.5 mg sublingual (placed under the tongue) black-cherry flavored tablets are available in pharmacies throughout the U.S. In March 2015, the U.S. Food and Drug Administration approved SAPHRIS for the acute treatment of manic or mixed episodes associated with bipolar I disorder in pediatric patients (ages 10 – 17).

17 Jul 2015

New study evaluates impact of U.S. Preventive Services Task Force Guidelines for PSA screening

Current U.S. Preventive Services Task Force Guidelines for prostate screening may be impacting the detection of high-risk prostate cancer.

14 Jul 2015

Single molecule appears to be central regulator driving cancer metastasis

Cancer is a disease of cell growth, but most tumors only become lethal once they metastasize or spread from their first location to sites throughout the body. For the first time, researchers at Thomas Jefferson University in Philadelphia report a single molecule that appears to be the central regulator driving metastasis in prostate cancer.

14 Jul 2015

New surgical method preserves long-term renal function following removal of renal tumours

Renal cell carcinomas are one of the most common types of cancer. In order to preserve its wide range of functions, every effort is made not to remove the entire kidney, but rather just a portion of it. A surgical method that preserves long-term renal function has now been carried out successfully for the first time in the Department of Urology at the MedUni Vienna and Vienna General Hospital.

13 Jul 2015

Revised work hour restrictions for resident physicians fail to improve surgical patient outcomes

Work hour restrictions for resident physicians, revised nationally four years ago largely to protect patients against physician trainees' fatigue-related errors, have not had the desired effect of lowering postoperative complication rates in several common surgical specialties, according to new study results.

9 Jul 2015

Study examines recent trends in community-based practices to improve management of localized prostate cancer

After years of overtreatment for patients with low-risk prostate cancer, rates of active surveillance/ watchful waiting increased sharply in 2010 through 2013, and high-risk disease was more often treated appropriately with potentially curative local treatment rather than androgen deprivation alone, according to a study in the July 7 issue of JAMA.

8 Jul 2015

Aytu BioScience now trading under new symbol following its corporate name change

Aytu BioScience, Inc., a specialty healthcare company focused on developing treatments for urological and related conditions, announced today that the company is now trading under the new symbol "AYTU," following its corporate name change, which became effective June 8, 2015.

7 Jul 2015

Allergan agrees to acquire exclusive worldwide rights to Merck's CGRP migraine development program

Allergan plc and Merck, known as MSD outside the United States and Canada, today announced that they have entered into an agreement under which Allergan will acquire the exclusive worldwide rights to Merck's investigational small molecule oral calcitonin gene-related peptide (CGRP) receptor antagonists, which are being developed for the treatment and prevention of migraine, subject to expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 (HSR).

7 Jul 2015

Study focuses on health risks from exposure to air pollution near roads and freeways

Policymakers and developers planning high-density housing near public transit with the goal of reducing automobile use and greenhouse gas emissions that contribute to global warming need a clearer understanding of the health risks from air pollution that may be created if that housing is also built near busy roads and freeways, according to new research by Keck School of Medicine of the University of Southern California scientists.

7 Jul 2015

Expectant management remains underused for men with low-risk prostate cancer

Monitoring men with very low- and low-risk prostate cancers using watchful waiting or active surveillance, called expectant management, is a useful approach for a large number of men with localized tumors and could spare them the debilitating side effects of aggressive treatments that are too often unnecessarily used in this patient population, a UCLA review of common practices in prostate cancer has found.

7 Jul 2015

Allergan enters into agreement to acquire Oculeve

Allergan plc, a leading global pharmaceutical company, and Oculeve, a development-stage medical device company focused on developing novel treatments for dry eye disease, today announced that they have entered into an agreement under which Allergan will acquire Oculeve in an all-cash transaction.

6 Jul 2015

Roswell Park, Lakeshore Cancer Center partner to improve access to cancer care for Nigerians

America's oldest cancer center and one of the world's newest oncology centers are partnering to improve access to cancer prevention, screening and care for the people of Nigeria. Roswell Park Cancer Institute and Lakeshore Cancer Center have announced an affiliation that will see Roswell Park faculty providing clinical consultations to assist LCC oncologists, who will also have access to both training at RPCI and continuing professional education seminars they can participate in remotely.

1 Jul 2015

Telesta submits Biologics License Application for MCNA to FDA

Telesta Therapeutics Inc. announced today that it has submitted electronically, through its U.S. agent, a Biologics License Application (BLA) to the United States Food and Drug Administration for MCNA. MCNA is Telesta's novel biologic immunotherapeutic for the treatment of high-risk non-muscle invasive bladder cancer patients who have failed first-line BCG therapy.

30 Jun 2015

Drugs used against impotence does not increase risk of malignant melanoma

Using drugs for impotence does not increase the risk of malignant melanoma, researchers from Umeå University in Sweden conclude in a publication in JAMA, a top US medical journal. These results contradict previous research indicating such an association.

23 Jun 2015

Bariatric surgery can significantly reduce urinary incontinence

For severely obese people, bariatric surgery may have a benefit besides dramatic weight loss: it can also substantially reduce urinary incontinence.

23 Jun 2015

Urology News and Research

Latest Urology News and Research

Prostate cancer patients more likely to receive medical care matched to level of risk

York scientists identify how some micro-RNAs can make prostate cancers resistant to radiotherapy

UCLA Health's hospitals named among nation's best in U.S. News and World Report

UC San Diego Health ranked again among nation's best hospitals by U.S. News & World Report

MD Anderson ranked No. 1 hospital in nation for cancer care

Allergan announces U.S. availability of SAPHRIS 2.5 mg tablets for children with bipolar I disorder

New study evaluates impact of U.S. Preventive Services Task Force Guidelines for PSA screening

Single molecule appears to be central regulator driving cancer metastasis

New surgical method preserves long-term renal function following removal of renal tumours

Revised work hour restrictions for resident physicians fail to improve surgical patient outcomes

Study examines recent trends in community-based practices to improve management of localized prostate cancer

Aytu BioScience now trading under new symbol following its corporate name change

Allergan agrees to acquire exclusive worldwide rights to Merck's CGRP migraine development program

Study focuses on health risks from exposure to air pollution near roads and freeways

Expectant management remains underused for men with low-risk prostate cancer

Allergan enters into agreement to acquire Oculeve

Roswell Park, Lakeshore Cancer Center partner to improve access to cancer care for Nigerians

Telesta submits Biologics License Application for MCNA to FDA

Drugs used against impotence does not increase risk of malignant melanoma

Bariatric surgery can significantly reduce urinary incontinence

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Urology News and Research

Latest Urology News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in